Advanced search

A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

(2017) ANNALS OF ONCOLOGY. 28(suppl. 5).
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Verma, B, A Awada, P Aftimos, P Lewalle, N Meuleman, J-P Machiels, G Catala, et al. 2017. “A Phase I Global Trial Targeting Multiple Solid and Hematologic Malignancies Through a NKG2D Receptor-based CAR-T Immunotherapy.” In Annals of Oncology. Vol. 28.
APA
Verma, B, Awada, A., Aftimos, P., Lewalle, P., Meuleman, N., Machiels, J.-P., Catala, G., et al. (2017). A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy. ANNALS OF ONCOLOGY (Vol. 28). Presented at the 42nd European Society for Medica Oncology congress (ESMO).
Vancouver
1.
Verma B, Awada A, Aftimos P, Lewalle P, Meuleman N, Machiels J-P, et al. A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy. ANNALS OF ONCOLOGY. 2017.
MLA
Verma, B et al. “A Phase I Global Trial Targeting Multiple Solid and Hematologic Malignancies Through a NKG2D Receptor-based CAR-T Immunotherapy.” Annals of Oncology. Vol. 28. 2017. Print.
@inproceedings{8549630,
  articleno    = {abstract 1210TiP},
  author       = {Verma, B and Awada, A and Aftimos, P and Lewalle, P and Meuleman, N and Machiels, J-P and Catala, G and Vandenneste, E and Brayer, J and Sallman, D and Sahebjam, S and Kerre, Tessa and Rottey, Sylvie and Odunsi, K and Wang, ES and Santanam, U and Lonez, C and Gilham, DE and Lehmann, F},
  booktitle    = {ANNALS OF ONCOLOGY},
  issn         = {0923-7534},
  language     = {eng},
  location     = {Madrid, Spain},
  number       = {suppl. 5},
  title        = {A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy},
  volume       = {28},
  year         = {2017},
}

Web of Science
Times cited: